Sphinganine

Sphinganine is a lipid of Sphingolipids (SP) class. Sphinganine is associated with abnormalities such as Sphingolipidoses, CLEFT LIP, CONGENITAL HEALED, Aortic aneurysm, familial thoracic 4, Morphologically altered structure and Atherosclerosis. The involved functions are known as Transcription, Genetic, Signal, Muscle Contraction, biological adaptation to stress and Gene Expression. Sphinganine often locates in Tissue membrane, Membrane, Protoplasm, Plasma membrane and Cytoplasmic. The associated genes with Sphinganine are SLC33A1 gene, HM13 gene, P4HTM gene, SPHK1 gene and SPHK2 gene. The related lipids are Sphingolipids, Phosphatidylserines, Sterols, Fatty Acids and inositolphosphorylceramide. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of Sphinganine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphinganine?

Sphinganine is suspected in Pulmonary Edema, Morphologically altered structure, Infection, HIV Infections, Pulmonary Hypertension, Exanthema and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphinganine

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Swine Diseases D013553 16 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Total 5

PubChem Associated disorders and diseases

What pathways are associated with Sphinganine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphinganine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphinganine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphinganine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphinganine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphinganine?

Knock-out

Knock-out are used in the study 'Sphingolipids are required for the stable membrane association of glycosylphosphatidylinositol-anchored proteins in yeast.' (Watanabe R et al., 2002) and Knock-out are used in the study 'Role for de novo sphingoid base biosynthesis in the heat-induced transient cell cycle arrest of Saccharomyces cerevisiae.' (Jenkins GM and Hannun YA, 2001).

Mouse Model

Mouse Model are used in the study 'Palmitate increases sphingosine-1-phosphate in C2C12 myotubes via upregulation of sphingosine kinase message and activity.' (Hu W et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphinganine

Download all related citations
Per page 10 20 50 100 | Total 790
Authors Title Published Journal PubMed Link
He Q et al. Fumonisin-induced tumor necrosis factor-alpha expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition. 2001 Toxicol. Appl. Pharmacol. pmid:11437650
Boujaoude LC et al. Cystic fibrosis transmembrane regulator regulates uptake of sphingoid base phosphates and lysophosphatidic acid: modulation of cellular activity of sphingosine 1-phosphate. 2001 J. Biol. Chem. pmid:11443135
Masur K et al. High PKC alpha and low E-cadherin expression contribute to high migratory activity of colon carcinoma cells. 2001 Mol. Biol. Cell pmid:11451996
Chung N et al. Phytosphingosine as a specific inhibitor of growth and nutrient import in Saccharomyces cerevisiae. 2001 J. Biol. Chem. pmid:11468289
Liu H et al. Reaction of fumonisin with glucose prevents promotion of hepatocarcinogenesis in female F344/N rats while maintaining normal hepatic sphinganine/sphingosine ratios. 2001 J. Agric. Food Chem. pmid:11513718
Bhandari N et al. Gender-related differences in subacute fumonisin B1 hepatotoxicity in BALB/c mice. 2001 Toxicology pmid:11522378
Garren L et al. The induction and persistence of altered sphingolipid biosynthesis in rats treated with fumonisin B1. 2001 Food Addit Contam pmid:11552753
Ito Y et al. Structural requirements of sphingosine molecules for inhibition of DNA primase: biochemical and computational analyses. 2001 Biochemistry pmid:11560507
Abnet CC et al. A cross-sectional study of human serum sphingolipids, diet and physiologic parameters. 2001 J. Nutr. pmid:11584099
Kim MS et al. Fumonisin B(1) induces apoptosis in LLC-PK(1) renal epithelial cells via a sphinganine- and calmodulin-dependent pathway. 2001 Toxicol. Appl. Pharmacol. pmid:11601888
Solfrizzo M et al. In vitro and in vivo studies to assess the effectiveness of cholestyramine as a binding agent for fumonisins. 2001 Mycopathologia pmid:11678589
Linn SC et al. Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruption. 2001 Biochem. Soc. Trans. pmid:11709083
Abnet CC et al. Sphingolipids as biomarkers of fumonisin exposure and risk of esophageal squamous cell carcinoma in china. 2001 Cancer Causes Control pmid:11714110
Tamura K et al. Characterization of an Arabidopsis cDNA encoding a subunit of serine palmitoyltransferase, the initial enzyme in sphingolipid biosynthesis. 2001 Plant Cell Physiol. pmid:11726713
Galvano F et al. DNA damage in human fibroblasts exposed to fumonisin B(1). 2002 Food Chem. Toxicol. pmid:11731033
Alemany R et al. Depolarisation induces rapid and transient formation of intracellular sphingosine-1-phosphate. 2001 FEBS Lett. pmid:11741596
Benaud C et al. Sphingosine 1-phosphate, present in serum-derived lipoproteins, activates matriptase. 2002 J. Biol. Chem. pmid:11792696
Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies). 2001 Natl Toxicol Program Tech Rep Ser pmid:11852482
da Rocha AB et al. Targeting protein kinase C: new therapeutic opportunities against high-grade malignant gliomas? 2002 Oncologist pmid:11854544
Diatlovitskaia EV [Biologically effective sphingolipids devoid of 4-trans-double bond in the sphingoid hydrocarbon chain]. 2002 Jan-Feb Bioorg. Khim. pmid:11875973